1. Identification of Serum Protein Markers for Breast Cancer Relapse With SELDI‐TOF MS
   Lei Lei et al, 2011, The Anatomical Record CrossRef
2. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China
   Juan Yang et al, 2016, PROTEOMICS CrossRef
3. Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment
   Daniel Ajona et al, 2019, Seminars in Cell & Developmental Biology CrossRef
4. Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4‐derived putative biomarker peptides in clinical serum samples
   Irene van den Broek et al, 2010, Rapid Communications in Mass Spectrometry CrossRef
5. Proteomic approaches in myeloid leukemia
   Jitendra Kumar Kanaujiya et al, 2011, ELECTROPHORESIS CrossRef
6. Isolation and Discovery of Small Peptides as Potential Biomarkers in Three Rice Cultivars Using Surface-Enhanced Laser Desorption/Ionization (SELDI) Time-of-Flight (TOF) Mass Spectrometry (MS)
   Yong Ho Lee et al, 2021, Journal of Plant Biology CrossRef
7. Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients
   Basem N. Azab et al, 2013, The American Journal of Surgery CrossRef
8. Biomarker discovery and clinical proteomics
   Jerzy Silberring et al, 2010, TrAC Trends in Analytical Chemistry CrossRef
9. Mass spectrometry of peptides and proteins from human blood
   Peihong Zhu et al, 2011, Mass Spectrometry Reviews CrossRef
10. The Application of SELDI-TOF-MS in Clinical Diagnosis of Cancers
    Chibo Liu, 2011, Journal of Biomedicine and Biotechnology CrossRef
11. Advances in Proteomic Technologies and Its Contribution to the Field of Cancer
    Mehdi Mesri, 2014, Advances in Medicine CrossRef
12. Serum and saliva protein levels in females with breast cancer
    SABAH ISA AL-MUHTASEB, 2014, Oncology Letters CrossRef
13. Ultra-sensitive high performance liquid chromatography–laser-induced fluorescence based proteomics for clinical applications
    Ajeetkumar Patil et al, 2015, Journal of Proteomics CrossRef
14. Serum Level of Fibrinogen A.ALPHA. Chain Fragment Increases in Chronic Thromboembolic Pulmonary Hypertension
    Toshiaki Yano et al, 2011, Circulation Journal CrossRef
15. Large-Scale Analysis of Breast Cancer-Related Conformational Changes in Proteins Using SILAC-SPROX
    Fang Liu et al, 2017, Journal of Proteome Research CrossRef
16. The absolute quantification of eight inter‐α‐trypsin inhibitor heavy chain 4 (ITIH4)‐derived peptides in serum from breast cancer patients
    Irene van den Broek et al, 2010, PROTEOMICS – Clinical Applications CrossRef
17. Protein Biomarkers for the Early Detection of Breast Cancer
    David E. Misek et al, 2011, International Journal of Proteomics CrossRef
18. Up‐regulated Proteins in the Fluid Bathing the Tumour Cell Microenvironment as Potential Serological Markers for Early Detection of Cancer of the Breast
    Pavel Gromov et al, 2010, Molecular Oncology CrossRef
19. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study
    Annemieke WJ Opstal-van Winden et al, 2011, BMC Cancer CrossRef
20. Protein Conformational Changes in Breast Cancer Sera Using Infrared Spectroscopic Analysis
    Hemendra Ghimire et al, 2020, Cancers CrossRef
21. Oncoproteomics: insight into current proteomic technologies in cancer biomarker discovery and treatment
    Shrestha Dutta et al, 2022, Journal of Proteins and Proteomics CrossRef
22. How has proteomics informed transfusion biology so far?
    Giancarlo Liumbruno et al, 2010, Critical Reviews in Oncology/Hematology CrossRef
23. Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth
    Sarah Davidson et al, 2020, Cell Reports CrossRef